Numerai’s CVS Health CVS Stock Holding History

Numerai’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-132,731	Closed	-$9.18M	–	229
2023 Q2	$9.18M	Buy	132,731 +103,338	+352%	+$7.35M	1.87%	8
2023 Q1	$2.18M	Buy	+29,393	New	+$2.46M	0.73%	48

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Numerai's CVS Position: Q3 2023 in Review

Numerai sold out of CVS Health (CVS) in Q3 2023, closing a stake of 132,731 shares — an estimated $9.18M sold.

Numerai first reported a position in CVS in Q1 2023 and held it in 2 quarters. The position peaked at $9.18M in Q2 2023. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Numerai reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
Numerai sold 132,731 CVS Health shares in Q3 2023, an estimated $9.18M.
Numerai first reported a position in CVS Health in Q1 2023 and held it in 2 quarters.
Numerai's CVS Health position peaked at $9.18M in Q2 2023.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Numerai's 13F filing for Q3 2023, filed 13 Nov 2023.